ID   SCN5A_RAT               Reviewed;        2019 AA.
AC   P15389; Q925G6;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   02-OCT-2024, entry version 170.
DE   RecName: Full=Sodium channel protein type 5 subunit alpha {ECO:0000305};
DE   AltName: Full=Sodium channel protein cardiac muscle subunit alpha;
DE   AltName: Full=Sodium channel protein type V subunit alpha;
DE   AltName: Full=Voltage-gated sodium channel subunit alpha Nav1.5;
GN   Name=Scn5a {ECO:0000312|RGD:3637};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=2554302; DOI=10.1073/pnas.86.20.8170;
RA   Rogart R.B., Cribbs L.L., Muglia L.K., Kephart D.D., Kaiser M.W.;
RT   "Molecular cloning of a putative tetrodotoxin-resistant rat heart Na+
RT   channel isoform.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:8170-8174(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=Sprague-Dawley;
RA   Korsgaard M.P.G., Christophersen P., Ahring P.K., Olesen S.;
RT   "Characterisation of the novel voltage-gated Na+ channel rNav1.5a isolated
RT   from the rat hippocampal progenitor stem cell line HiB5.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   MUTAGENESIS OF ASP-1612.
RX   PubMed=9417050; DOI=10.1074/jbc.273.1.80;
RA   Benzinger G.R., Kyle J.W., Blumenthal K.M., Hanck D.A.;
RT   "A specific interaction between the cardiac sodium channel and site-3 toxin
RT   anthopleurin B.";
RL   J. Biol. Chem. 273:80-84(1998).
RN   [4]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15579534; DOI=10.1073/pnas.0403711101;
RA   Mohler P.J., Rivolta I., Napolitano C., LeMaillet G., Lambert S.,
RA   Priori S.G., Bennett V.;
RT   "Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-
RT   G and expression of Nav1.5 on the surface of cardiomyocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:17533-17538(2004).
RN   [5]
RP   ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=18386309; DOI=10.1080/01677060701672077;
RA   Wang J., Ou S.-W., Wang Y.-J., Zong Z.-H., Lin L., Kameyama M.,
RA   Kameyama A.;
RT   "New variants of Nav1.5/SCN5A encode Na+ channels in the brain.";
RL   J. Neurogenet. 22:57-75(2008).
RN   [6]
RP   INTERACTION WITH PKP2, AND SUBCELLULAR LOCATION.
RX   PubMed=19661460; DOI=10.1161/circresaha.109.201418;
RA   Sato P.Y., Musa H., Coombs W., Guerrero-Serna G., Patino G.A., Taffet S.M.,
RA   Isom L.L., Delmar M.;
RT   "Loss of plakophilin-2 expression leads to decreased sodium current and
RT   slower conduction velocity in cultured cardiac myocytes.";
RL   Circ. Res. 105:523-526(2009).
RN   [7]
RP   ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=19376164; DOI=10.1016/j.neures.2009.04.003;
RA   Wang J., Ou S.-W., Wang Y.-J., Kameyama M., Kameyama A., Zong Z.-H.;
RT   "Analysis of four novel variants of Nav1.5/SCN5A cloned from the brain.";
RL   Neurosci. Res. 64:339-347(2009).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21617128; DOI=10.1161/circresaha.111.247023;
RA   Sato P.Y., Coombs W., Lin X., Nekrasova O., Green K.J., Isom L.L.,
RA   Taffet S.M., Delmar M.;
RT   "Interactions between ankyrin-G, Plakophilin-2, and Connexin43 at the
RT   cardiac intercalated disc.";
RL   Circ. Res. 109:193-201(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484; SER-485 AND THR-487, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [10]
RP   FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY REGULATION, AND MUTAGENESIS OF
RP   LEU-869.
RX   PubMed=24497506; DOI=10.1073/pnas.1324189111;
RA   Gajewiak J., Azam L., Imperial J., Walewska A., Green B.R.,
RA   Bandyopadhyay P.K., Raghuraman S., Ueberheide B., Bern M., Zhou H.M.,
RA   Minassian N.A., Hagan R.H., Flinspach M., Liu Y., Bulaj G., Wickenden A.D.,
RA   Olivera B.M., Yoshikami D., Zhang M.M.;
RT   "A disulfide tether stabilizes the block of sodium channels by the
RT   conotoxin muO[section sign]-GVIIJ.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:2758-2763(2014).
RN   [11]
RP   SITE CYS-374.
RX   PubMed=26039939; DOI=10.1021/acs.biochem.5b00390;
RA   Zhang M.M., Gajewiak J., Azam L., Bulaj G., Olivera B.M., Yoshikami D.;
RT   "Probing the redox states of sodium channel cysteines at the binding site
RT   of muO[section sign]-conotoxin GVIIJ.";
RL   Biochemistry 54:3911-3920(2015).
RN   [12] {ECO:0007744|PDB:6UZ0, ECO:0007744|PDB:6UZ3}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.24 ANGSTROMS) OF 119-1780 IN COMPLEX
RP   WITH INHIBITOR, FUNCTION, TRANSPORTER ACTIVITY, SUBUNIT, TOPOLOGY, AND
RP   GLYCOSYLATION AT ASN-319.
RX   PubMed=31866066; DOI=10.1016/j.cell.2019.11.041;
RA   Jiang D., Shi H., Tonggu L., Gamal El-Din T.M., Lenaeus M.J., Zhao Y.,
RA   Yoshioka C., Zheng N., Catterall W.A.;
RT   "Structure of the Cardiac Sodium Channel.";
RL   Cell 180:122-134.e10(2020).
CC   -!- FUNCTION: Pore-forming subunit of Nav1.5, a voltage-gated sodium (Nav)
CC       channel that directly mediates the depolarizing phase of action
CC       potentials in excitable membranes. Navs, also called VGSCs (voltage-
CC       gated sodium channels) or VDSCs (voltage-dependent sodium channels),
CC       operate by switching between closed and open conformations depending on
CC       the voltage difference across the membrane. In the open conformation
CC       they allow Na(+) ions to selectively pass through the pore, along their
CC       electrochemical gradient. The influx of Na(+) ions provokes membrane
CC       depolarization, initiating the propagation of electrical signals
CC       throughout cells and tissues (PubMed:24497506, PubMed:31866066). Nav1.5
CC       is the predominant sodium channel expressed in myocardial cells and it
CC       is responsible for the initial upstroke of the action potential in
CC       cardiac myocytes, thereby initiating the heartbeat (By similarity).
CC       Required for normal electrical conduction including formation of the
CC       infranodal ventricular conduction system and normal action potential
CC       configuration, as a result of its interaction with XIRP2 (By
CC       similarity). {ECO:0000250|UniProtKB:Q14524,
CC       ECO:0000250|UniProtKB:Q9JJV9, ECO:0000269|PubMed:24497506,
CC       ECO:0000269|PubMed:31866066}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(in) = Na(+)(out); Xref=Rhea:RHEA:34963,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:24497506,
CC         ECO:0000269|PubMed:31866066};
CC   -!- ACTIVITY REGULATION: Channel inactivation is regulated by intracellular
CC       calcium levels (By similarity). It is a tetrodotoxin-resistant voltage-
CC       gated Na(+) channel (Nav) (PubMed:24497506).
CC       {ECO:0000250|UniProtKB:Q14524, ECO:0000269|PubMed:24497506}.
CC   -!- SUBUNIT: Cannot form the same regulatory interactions with beta
CC       subunits as other Navs do (PubMed:31866066). Interacts with the PDZ
CC       domain of the syntrophin SNTA1, SNTB1 and SNTB2. Interacts with NEDD4,
CC       NEDD4L, WWP2 and GPD1L. Interacts with CALM. Interacts with FGF13; the
CC       interaction is direct and may regulate SNC5A density at membranes and
CC       function. May also interact with FGF12 and FGF14. Interacts with ANK3
CC       (By similarity). Interacts with PKP2 (via N-terminus)
CC       (PubMed:19661460). Interacts with TMEM233 (By similarity). Interacts
CC       with XIRP2; the interaction is required for normal action potential
CC       configuration in the heart (By similarity).
CC       {ECO:0000250|UniProtKB:Q14524, ECO:0000250|UniProtKB:Q9JJV9,
CC       ECO:0000269|PubMed:19661460, ECO:0000269|PubMed:31866066}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21617128};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:31866066}. Cytoplasm,
CC       perinuclear region {ECO:0000250|UniProtKB:Q14524}. Cell membrane,
CC       sarcolemma, T-tubule {ECO:0000269|PubMed:15579534}. Cell junction
CC       {ECO:0000269|PubMed:19661460}. Note=RANGRF promotes trafficking to the
CC       cell membrane. Colocalizes with PKP2 at intercalated disks in the heart
CC       (PubMed:19661460). {ECO:0000250|UniProtKB:Q14524,
CC       ECO:0000269|PubMed:19661460}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P15389-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P15389-2; Sequence=VSP_037482;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in the heart (PubMed:19661460).
CC       Also expressed in adult and fetal brain, spinal cord, testis, and at
CC       moderate levels in kidney, adrenal gland, lung, skeletal muscle,
CC       spleen, stomach and bladder. {ECO:0000269|PubMed:18386309,
CC       ECO:0000269|PubMed:19376164, ECO:0000269|PubMed:19661460}.
CC   -!- TISSUE SPECIFICITY: [Isoform 2]: Expressed in brain.
CC       {ECO:0000269|PubMed:18386309}.
CC   -!- DOMAIN: The sequence contains 4 internal repeats, each with 5
CC       hydrophobic segments (S1, S2, S3, S5, S6) and one positively charged
CC       segment (S4). Segments S4 are probably the voltage-sensors and are
CC       characterized by a series of positively charged amino acids at every
CC       third position. {ECO:0000305}.
CC   -!- DOMAIN: The IQ domain mediates association with calmodulin.
CC       {ECO:0000250|UniProtKB:Q14524}.
CC   -!- PTM: N-glycosylated at Asn-319, hinders potential interaction with
CC       regulatory subunits. {ECO:0000269|PubMed:31866066}.
CC   -!- PTM: Phosphorylation at Ser-1505 by PKC in a highly conserved
CC       cytoplasmic loop slows inactivation of the sodium channel and reduces
CC       peak sodium currents. Regulated through phosphorylation by CaMK2D.
CC       {ECO:0000250|UniProtKB:Q14524, ECO:0000250|UniProtKB:Q9JJV9}.
CC   -!- PTM: Ubiquitinated by NEDD4L; which promotes its endocytosis. Does not
CC       seem to be ubiquitinated by NEDD4 or WWP2.
CC       {ECO:0000250|UniProtKB:Q14524}.
CC   -!- PTM: Lacks the cysteine which covalently binds the conotoxin GVIIJ.
CC       This cysteine (position 869) is speculated in other sodium channel
CC       subunits alpha to be implied in covalent binding with the sodium
CC       channel subunit beta-2 or beta-4. {ECO:0000305|PubMed:24497506}.
CC   -!- MISCELLANEOUS: Na(+) channels in mammalian cardiac membrane have
CC       functional properties quite distinct from Na(+) channels in nerve and
CC       skeletal muscle.
CC   -!- SIMILARITY: Belongs to the sodium channel (TC 1.A.1.10) family.
CC       Nav1.5/SCN5A subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M27902; AAA42114.1; -; mRNA.
DR   EMBL; AF353637; AAK38884.1; -; mRNA.
DR   PIR; A33996; A33996.
DR   RefSeq; NP_001153634.1; NM_001160162.1.
DR   RefSeq; NP_037257.1; NM_013125.2.
DR   PDB; 6UZ0; EM; 3.24 A; A=1-1898.
DR   PDB; 6UZ3; EM; 3.50 A; A=1-1898.
DR   PDB; 7FBS; EM; 3.40 A; A=1-1898.
DR   PDB; 7K18; EM; 3.30 A; A=1-1898.
DR   PDB; 7XSU; EM; 3.40 A; A=1-1898.
DR   PDB; 8F6P; EM; 3.20 A; A=1-1898.
DR   PDB; 8T6L; EM; 3.30 A; A=1-1931.
DR   PDBsum; 6UZ0; -.
DR   PDBsum; 6UZ3; -.
DR   PDBsum; 7FBS; -.
DR   PDBsum; 7K18; -.
DR   PDBsum; 7XSU; -.
DR   PDBsum; 8F6P; -.
DR   PDBsum; 8T6L; -.
DR   AlphaFoldDB; P15389; -.
DR   BMRB; P15389; -.
DR   SMR; P15389; -.
DR   BioGRID; 247694; 1.
DR   DIP; DIP-60063N; -.
DR   IntAct; P15389; 2.
DR   STRING; 10116.ENSRNOP00000060180; -.
DR   BindingDB; P15389; -.
DR   ChEMBL; CHEMBL3866; -.
DR   DrugCentral; P15389; -.
DR   GuidetoPHARMACOLOGY; 582; -.
DR   GlyCosmos; P15389; 13 sites, No reported glycans.
DR   GlyGen; P15389; 14 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; P15389; -.
DR   PhosphoSitePlus; P15389; -.
DR   SwissPalm; P15389; -.
DR   PaxDb; 10116-ENSRNOP00000060180; -.
DR   ABCD; P15389; 2 sequenced antibodies.
DR   GeneID; 25665; -.
DR   KEGG; rno:25665; -.
DR   UCSC; RGD:3637; rat. [P15389-1]
DR   AGR; RGD:3637; -.
DR   CTD; 6331; -.
DR   RGD; 3637; Scn5a.
DR   eggNOG; KOG2301; Eukaryota.
DR   InParanoid; P15389; -.
DR   OrthoDB; 1110761at2759; -.
DR   PhylomeDB; P15389; -.
DR   PRO; PR:P15389; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0005901; C:caveola; ISS:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:BHF-UCL.
DR   GO; GO:0014704; C:intercalated disc; IDA:BHF-UCL.
DR   GO; GO:0016328; C:lateral plasma membrane; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0042383; C:sarcolemma; ISO:RGD.
DR   GO; GO:0034706; C:sodium channel complex; ISO:RGD.
DR   GO; GO:0030315; C:T-tubule; IDA:BHF-UCL.
DR   GO; GO:0001518; C:voltage-gated sodium channel complex; ISS:BHF-UCL.
DR   GO; GO:0030018; C:Z disc; ISS:BHF-UCL.
DR   GO; GO:0030506; F:ankyrin binding; IDA:RGD.
DR   GO; GO:0005516; F:calmodulin binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0017134; F:fibroblast growth factor binding; IPI:RGD.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; ISO:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; ISS:UniProtKB.
DR   GO; GO:0086060; F:voltage-gated sodium channel activity involved in AV node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086061; F:voltage-gated sodium channel activity involved in bundle of His cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086006; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0086062; F:voltage-gated sodium channel activity involved in Purkinje myocyte action potential; ISS:BHF-UCL.
DR   GO; GO:0086063; F:voltage-gated sodium channel activity involved in SA node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086014; P:atrial cardiac muscle cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086016; P:AV node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086067; P:AV node cell to bundle of His cell communication; ISS:BHF-UCL.
DR   GO; GO:0003360; P:brainstem development; IEP:RGD.
DR   GO; GO:0086043; P:bundle of His cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; ISS:BHF-UCL.
DR   GO; GO:0060048; P:cardiac muscle contraction; ISS:BHF-UCL.
DR   GO; GO:0003231; P:cardiac ventricle development; ISO:RGD.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0051899; P:membrane depolarization; ISS:BHF-UCL.
DR   GO; GO:0086010; P:membrane depolarization during action potential; ISS:BHF-UCL.
DR   GO; GO:0098912; P:membrane depolarization during atrial cardiac muscle cell action potential; ISO:RGD.
DR   GO; GO:0086045; P:membrane depolarization during AV node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086048; P:membrane depolarization during bundle of His cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0086047; P:membrane depolarization during Purkinje myocyte cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086046; P:membrane depolarization during SA node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0019228; P:neuronal action potential; IBA:GO_Central.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEP:RGD.
DR   GO; GO:0045760; P:positive regulation of action potential; IMP:RGD.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IMP:RGD.
DR   GO; GO:0010460; P:positive regulation of heart rate; IMP:RGD.
DR   GO; GO:0010765; P:positive regulation of sodium ion transport; ISS:BHF-UCL.
DR   GO; GO:0060371; P:regulation of atrial cardiac muscle cell membrane depolarization; ISS:BHF-UCL.
DR   GO; GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; ISS:BHF-UCL.
DR   GO; GO:0086004; P:regulation of cardiac muscle cell contraction; ISS:BHF-UCL.
DR   GO; GO:0002027; P:regulation of heart rate; ISS:BHF-UCL.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; ISS:BHF-UCL.
DR   GO; GO:1902305; P:regulation of sodium ion transmembrane transport; ISS:BHF-UCL.
DR   GO; GO:0060373; P:regulation of ventricular cardiac muscle cell membrane depolarization; ISS:BHF-UCL.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; ISS:BHF-UCL.
DR   GO; GO:0014894; P:response to denervation involved in regulation of muscle adaptation; IMP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; ISO:RGD.
DR   GO; GO:0086015; P:SA node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0098719; P:sodium ion import across plasma membrane; IMP:BHF-UCL.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IMP:RGD.
DR   GO; GO:0006814; P:sodium ion transport; ISS:UniProtKB.
DR   GO; GO:0021537; P:telencephalon development; IEP:RGD.
DR   GO; GO:0086005; P:ventricular cardiac muscle cell action potential; ISO:RGD.
DR   CDD; cd13433; Na_channel_gate; 1.
DR   Gene3D; 1.10.287.70; -; 4.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   Gene3D; 1.20.5.1190; iswi atpase; 1.
DR   Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 4.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR008053; Na_channel_a5su.
DR   InterPro; IPR001696; Na_channel_asu.
DR   InterPro; IPR044564; Na_chnl_inactivation_gate.
DR   InterPro; IPR010526; Na_trans_assoc_dom.
DR   InterPro; IPR024583; Na_trans_cytopl.
DR   InterPro; IPR043203; VGCC_Ca_Na.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR10037:SF206; SODIUM CHANNEL PROTEIN TYPE 5 SUBUNIT ALPHA; 1.
DR   PANTHER; PTHR10037; VOLTAGE-GATED CATION CHANNEL CALCIUM AND SODIUM; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   Pfam; PF06512; Na_trans_assoc; 1.
DR   Pfam; PF11933; Na_trans_cytopl; 1.
DR   PRINTS; PR00170; NACHANNEL.
DR   PRINTS; PR01666; NACHANNEL5.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calmodulin-binding; Cell junction;
KW   Cell membrane; Cytoplasm; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Methylation; Phosphoprotein; Reference proteome;
KW   Repeat; Sodium; Sodium channel; Sodium transport; Transmembrane;
KW   Transmembrane helix; Transport; Ubl conjugation; Voltage-gated channel.
FT   CHAIN           1..2019
FT                   /note="Sodium channel protein type 5 subunit alpha"
FT                   /id="PRO_0000048498"
FT   TOPO_DOM        1..130
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        131..150
FT                   /note="Helical; Name=S1 of repeat I"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        151..158
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        159..180
FT                   /note="Helical; Name=S2 of repeat I"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        181..189
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        190..210
FT                   /note="Helical; Name=S3 of repeat I"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        211..217
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        218..237
FT                   /note="Helical; Name=S4 of repeat I"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        238..250
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        251..273
FT                   /note="Helical; Name=S5 of repeat I"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        274..358
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        359..379
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        380..387
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        388..414
FT                   /note="Helical; Name=S6 of repeat I"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        415..720
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        721..738
FT                   /note="Helical; Name=S1 of repeat II"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        739..747
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        748..770
FT                   /note="Helical; Name=S2 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        771..776
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        777..797
FT                   /note="Helical; Name=S3 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        798..807
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        808..822
FT                   /note="Helical; Name=S4 of repeat II"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        823..839
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        840..861
FT                   /note="Helical; Name=S5 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        862..887
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        888..906
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        907..915
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        916..944
FT                   /note="Helical; Name=S6 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        945..1205
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1206..1227
FT                   /note="Helical; Name=S1 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1228..1238
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1239..1261
FT                   /note="Helical; Name=S2 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1262..1270
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1271..1293
FT                   /note="Helical; Name=S3 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1294..1299
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1300..1319
FT                   /note="Helical; Name=S4 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1320..1332
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1333..1357
FT                   /note="Helical; Name=S5 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1358..1402
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        1403..1424
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        1425..1447
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1448..1472
FT                   /note="Helical; Name=S6 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1473..1530
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1531..1549
FT                   /note="Helical; Name=S1 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1550..1560
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1561..1582
FT                   /note="Helical; Name=S2 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1583..1591
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1592..1614
FT                   /note="Helical; Name=S3 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1615..1621
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1622..1642
FT                   /note="Helical; Name=S4 of repeat IV"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        1643..1652
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1653..1681
FT                   /note="Helical; Name=S5 of repeat IV"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        1682..1699
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        1700..1716
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        1717..1747
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1748..1773
FT                   /note="Helical; Name=S6 of repeat IV"
FT                   /evidence="ECO:0000305|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0"
FT   TOPO_DOM        1774..2019
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REPEAT          114..421
FT                   /note="I"
FT                   /evidence="ECO:0000305"
FT   REPEAT          700..972
FT                   /note="II"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1189..1503
FT                   /note="III"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1512..1809
FT                   /note="IV"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          1903..1932
FT                   /note="IQ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   REGION          27..64
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          462..588
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          618..655
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          996..1144
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1841..1903
FT                   /note="Interaction with FGF13"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   REGION          1964..2019
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1977..1980
FT                   /note="Interaction with NEDD4, NEDD4L and WWP2"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   COMPBIAS        481..501
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        504..527
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1021..1040
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1057..1071
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1096..1126
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1964..1995
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            374
FT                   /note="Cys residue near the selectivity filter, which has a
FT                   free thiol that is susceptible to reaction with
FT                   methanethiosulfonate (MTSET); Sodium current is
FT                   irreversibly blocked by MTSET"
FT                   /evidence="ECO:0000250|UniProtKB:P04775,
FT                   ECO:0000269|PubMed:26039939"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   MOD_RES         39
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   MOD_RES         458
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   MOD_RES         461
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   MOD_RES         484
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         485
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         487
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         498
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   MOD_RES         511
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   MOD_RES         527
FT                   /note="Dimethylated arginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   MOD_RES         527
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   MOD_RES         540
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JJV9"
FT   MOD_RES         572
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   MOD_RES         665
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   MOD_RES         668
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   MOD_RES         1505
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   CARBOHYD        215
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        284
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        289
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        292
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        319
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0, ECO:0007744|PDB:6UZ3"
FT   CARBOHYD        329
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        741
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        804
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        865
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1367
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1376
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1382
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1390
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        281..336
FT                   /evidence="ECO:0000269|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0, ECO:0007744|PDB:6UZ3"
FT   DISULFID        909..918
FT                   /evidence="ECO:0000269|PubMed:31866066,
FT                   ECO:0007744|PDB:6UZ0, ECO:0007744|PDB:6UZ3"
FT   VAR_SEQ         1080..1132
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_037482"
FT   MUTAGEN         869
FT                   /note="L->C: >1000-fold increase of sensitivity to the
FT                   conotoxin GVIIJ(SSG)."
FT                   /evidence="ECO:0000269|PubMed:24497506"
FT   MUTAGEN         1612
FT                   /note="D->N,R: Little change in voltage-dependence of
FT                   conductance and decrease in affinity to the sea anemone
FT                   toxin anthopleurin-B (residue Lys-37)."
FT                   /evidence="ECO:0000269|PubMed:9417050"
FT   HELIX           18..31
FT                   /evidence="ECO:0007829|PDB:8T6L"
FT   HELIX           57..59
FT                   /evidence="ECO:0007829|PDB:8T6L"
FT   HELIX           67..69
FT                   /evidence="ECO:0007829|PDB:8T6L"
FT   TURN            74..78
FT                   /evidence="ECO:0007829|PDB:8T6L"
FT   TURN            86..89
FT                   /evidence="ECO:0007829|PDB:8T6L"
FT   STRAND          90..96
FT                   /evidence="ECO:0007829|PDB:8T6L"
FT   STRAND          102..107
FT                   /evidence="ECO:0007829|PDB:8T6L"
FT   TURN            112..114
FT                   /evidence="ECO:0007829|PDB:8T6L"
FT   HELIX           120..130
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           132..149
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           156..179
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          182..185
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            189..191
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           195..210
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           218..228
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           229..233
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           235..250
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           252..272
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           276..278
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          280..283
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          291..293
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           297..299
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          301..303
FT                   /evidence="ECO:0007829|PDB:8T6L"
FT   HELIX           305..310
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           312..314
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          321..324
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          329..333
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          340..343
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           350..352
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          356..358
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           359..370
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            372..374
FT                   /evidence="ECO:0007829|PDB:6UZ0"
FT   HELIX           375..385
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           388..390
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           391..398
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            399..402
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           403..429
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           701..714
FT                   /evidence="ECO:0007829|PDB:6UZ0"
FT   HELIX           720..736
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          739..741
FT                   /evidence="ECO:0007829|PDB:8T6L"
FT   HELIX           744..771
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           774..777
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           781..797
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           807..809
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           810..813
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           814..821
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           824..836
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            837..840
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           841..868
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           870..873
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          875..878
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          884..886
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           887..899
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           904..912
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           915..944
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1194..1205
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1207..1224
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            1229..1233
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1236..1269
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1272..1291
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          1297..1299
FT                   /evidence="ECO:0007829|PDB:6UZ0"
FT   HELIX           1302..1305
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1306..1315
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            1316..1318
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1320..1358
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            1359..1362
FT                   /evidence="ECO:0007829|PDB:7K18"
FT   STRAND          1363..1368
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            1369..1372
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            1377..1379
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1383..1388
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            1389..1391
FT                   /evidence="ECO:0007829|PDB:8T6L"
FT   STRAND          1395..1399
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          1405..1407
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1408..1418
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          1420..1422
FT                   /evidence="ECO:0007829|PDB:6UZ3"
FT   HELIX           1423..1430
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          1435..1438
FT                   /evidence="ECO:0007829|PDB:6UZ0"
FT   TURN            1442..1445
FT                   /evidence="ECO:0007829|PDB:7K18"
FT   HELIX           1448..1458
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1461..1481
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            1482..1484
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1491..1504
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          1516..1518
FT                   /evidence="ECO:0007829|PDB:8T6L"
FT   HELIX           1521..1527
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1530..1548
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1556..1581
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          1583..1585
FT                   /evidence="ECO:0007829|PDB:6UZ0"
FT   HELIX           1586..1590
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1592..1611
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1614..1617
FT                   /evidence="ECO:0007829|PDB:6UZ0"
FT   HELIX           1623..1629
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1630..1640
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1644..1680
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            1681..1683
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          1692..1694
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          1696..1698
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1699..1710
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            1711..1714
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   HELIX           1715..1723
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   TURN            1727..1729
FT                   /evidence="ECO:0007829|PDB:8F6P"
FT   STRAND          1737..1739
FT                   /evidence="ECO:0007829|PDB:6UZ0"
FT   HELIX           1747..1779
FT                   /evidence="ECO:0007829|PDB:8F6P"
SQ   SEQUENCE   2019 AA;  227367 MW;  CFC3B03CEAE708AD CRC64;
     MANLLLPRGT SSFRRFTRES LAAIEKRMAE KQARGGSATS QESREGLQEE EAPRPQLDLQ
     ASKKLPDLYG NPPRELIGEP LEDLDPFYST QKTFIVLNKG KTIFRFSATN ALYVLSPFHP
     VRRAAVKILV HSLFSMLIMC TILTNCVFMA QHDPPPWTKY VEYTFTAIYT FESLVKILAR
     GFCLHAFTFL RDPWNWLDFS VIVMAYTTEF VDLGNVSALR TFRVLRALKT ISVISGLKTI
     VGALIQSVKK LADVMVLTVF CLSVFALIGL QLFMGNLRHK CVRNFTELNG TNGSVEADGL
     VWNSLDVYLN DPANYLLKNG TTDVLLCGNS SDAGTCPEGY RCLKAGENPD HGYTSFDSFA
     WAFLALFRLM TQDCWERLYQ QTLRSAGKIY MIFFMLVIFL GSFYLVNLIL AVVAMAYEEQ
     NQATIAETEE KEKRFQEAME MLKKEHEALT IRGVDTVSRS SLEMSPLAPV TNHERKSKRR
     KRLSSGTEDG GDDRLPKSDS EDGPRALNQL SLTHGLSRTS MRPRSSRGSI FTFRRRDQGS
     EADFADDENS TAGESESHRT SLLVPWPLRH PSAQGQPGPG ASAPGYVLNG KRNSTVDCNG
     VVSLLGAGDA EATSPGSYLL RPMVLDRPPD TTTPSEEPGG PQMLTPQAPC ADGFEEPGAR
     QRALSAVSVL TSALEELEES HRKCPPCWNR FAQHYLIWEC CPLWMSIKQK VKFVVMDPFA
     DLTITMCIVL NTLFMALEHY NMTAEFEEML QVGNLVFTGI FTAEMTFKII ALDPYYYFQQ
     GWNIFDSIIV ILSLMELGLS RMGNLSVLRS FRLLRVFKLA KSWPTLNTLI KIIGNSVGAL
     GNLTLVLAII VFIFAVVGMQ LFGKNYSELR HRISDSGLLP RWHMMDFFHA FLIIFRILCG
     EWIETMWDCM EVSGQSLCLL VFLLVMVIGN LVVLNLFLAL LLSSFSADNL TAPDEDGEMN
     NLQLALARIQ RGLRFVKRTT WDFCCGILRR RPKKPAALAT HSQLPSCITA PRSPPPPEVE
     KVPPARKETR FEEDKRPGQG TPGDSEPVCV PIAVAESDTE DQEEDEENSL GTEEESSKQE
     SQVVSGGHEP YQEPRAWSQV SETTSSEAGA STSQADWQQE QKTEPQAPGC GETPEDSYSE
     GSTADMTNTA DLLEQIPDLG EDVKDPEDCF TEGCVRRCPC CMVDTTQSPG KVWWRLRKTC
     YRIVEHSWFE TFIIFMILLS SGALAFEDIY LEERKTIKVL LEYADKMFTY VFVLEMLLKW
     VAYGFKKYFT NAWCWLDFLI VDVSLVSLVA NTLGFAEMGP IKSLRTLRAL RPLRALSRFE
     GMRVVVNALV GAIPSIMNVL LVCLIFWLIF SIMGVNLFAG KFGRCINQTE GDLPLNYTIV
     NNKSECESFN VTGELYWTKV KVNFDNVGAG YLALLQVATF KGWMDIMYAA VDSRGYEEQP
     QWEDNLYMYI YFVVFIIFGS FFTLNLFIGV IIDNFNQQKK KLGGQDIFMT EEQKKYYNAM
     KKLGSKKPQK PIPRPLNKYQ GFIFDIVTKQ AFDVTIMFLI CLNMVTMMVE TDDQSPEKVN
     ILAKINLLFV AIFTGECIVK MAALRHYYFT NSWNIFDFVV VILSIVGTVL SDIIQKYFFS
     PTLFRVIRLA RIGRILRLIR GAKGIRTLLF ALMMSLPALF NIGLLLFLVM FIYSIFGMAN
     FAYVKWEAGI DDMFNFQTFA NSMLCLFQIT TSAGWDGLLS PILNTGPPYC DPNLPNSNGS
     RGNCGSPAVG ILFFTTYIII SFLIVVNMYI AIILENFSVA TEESTEPLSE DDFDMFYEIW
     EKFDPEATQF IEYLALSDFA DALSEPLRIA KPNQISLINM DLPMVSGDRI HCMDILFAFT
     KRVLGESGEM DALKIQMEEK FMAANPSKIS YEPITTTLRR KHEEVSATVI QRAFRRHLLQ
     RSVKHASFLF RQQAGGSGLS DEDAPEREGL IAYMMNGNFS RRSAPLSSSS ISSTSFPPSY
     DSVTRATSDN LPVRASDYSR SEDLADFPPS PDRDRESIV
//
